SCHEMBL21067563

SCHEMBL21067563

Nc1ncnc2c1ncn2[C@@H]1O[C@@H](COP(=O)(S)S)[C@H](O)[C@H]1O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 10/20 0.83
▸ P2RY2 P41231 3/20 0.83
▸ SRC P12931 2/20 0.83
▸ SMN1; SMN2 Q16637 2/20 0.83
▸ TRPM2 O94759 2/20 0.83
▸ TAS1R3 Q7RTX0 2/20 0.83
▸ TAS1R1 Q7RTX1 2/20 0.83
▸ P2RY11 Q96G91 2/20 0.83
▸ DNPH1 O43598 1/20 0.83
▸ PRKAB2 O43741 1/20 0.83
▸ LDHA P00338 1/20 0.83
▸ ADRB2 P07550 1/20 0.83
▸ FBP1 P09467 1/20 0.83
▸ ADORA1 P30542 1/20 0.83
▸ PRKAG1 P54619 1/20 0.83
▸ PRKAA2 P54646 1/20 0.83
▸ PDE4D Q08499 1/20 0.83
▸ KCNH2 Q12809 1/20 0.83
▸ PRKAA1 Q13131 1/20 0.83
▸ PDE3A Q14432 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7459421 0.93 P2RY1 (0.85) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL4954945 0.93 P2RY1 (0.85) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL13996419 0.93 P2RY1 (0.85) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15270623 0.92 P2RY1 (0.94) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL18785114 0.91 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Vidarabine Phosphate SCHEMBL144996 0.91 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL3487544 0.91 P2RY1 (0.84) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL3046222 0.91 P2RY1 (0.92) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL5588 0.91 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13374692 0.91 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback